We read with interest the eloquent opinion piece by Dr. Messerli [1] questioning the utility of a “glorified high-tech gadget,” also known as renal denervation (RDN), as an adjunct therapeutic approach to lower blood pressure (BP) in patients with uncontrolled hypertension. Views expressed should build on the entirety of scientific evidence available—this is perhaps where the viewpoint has some shortcomings.
Murray Esler
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Murray
Contact Murray, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack